cladribine has been researched along with Dermatitis Medicamentosa in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguado Lobo, M; Espinosa Lara, P; Jiménez-Reyes, J; Quirós Redondo, V | 1 |
| Messina, J; Nethers, K; Seminario-Vidal, L | 1 |
| Andritsos, LA; Grever, MR; Kaffenberger, BH; Kuehn, GJ; Li, D; Wang, RF | 1 |
| Andritsos, LA; Grever, MR; Kaffenberger, BH; Kuehn, GJ; Wang, RF | 1 |
| Bennett, M; Chubar, Y | 1 |
| Fijnheer, R; Gerrits, WB; Kluin-Nelemans, HC; Oldhoff, JM; Pasmans, SG; Van 't Wout, JW; van Dobbenburgh, OA; Van Doormaal, JJ; Verhoef, G | 1 |
| Chiari, AC; Cintra, ML; de Souza, EM; Lorand-Metze, I; Pagnano, KB; Rossini, MS | 1 |
| Aractingi, S; Bastie, JN; Castaigne, S; Chosidow, O; Meunier, P | 1 |
| Hershko, C; Rosenmann, E; Zevin, S | 1 |
| Cohen, PR; Kurzrock, R | 2 |
| Blasinska-Morawiec, M; Dabkowski, J; Robak, E; Robak, T; Sysa-Jedrzejowska, A | 1 |
| Błasińska-Morawiec, M; Błoński, JZ; Robak, T; Skotnicki, AB; Urbańska-Ryś, H | 1 |
1 trial(s) available for cladribine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Cladribine therapy for systemic mastocytosis.
Topics: Adult; Aged; Antimetabolites; Biomarkers; Cladribine; Drug Eruptions; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mastocytosis, Systemic; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome | 2003 |
12 other study(ies) available for cladribine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol.
Topics: Aged; Allopurinol; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Eruptions; Drug Monitoring; Exanthema; Humans; Leukemia, Hairy Cell; Male; Pigmentation Disorders; Purpura; Severity of Illness Index; Treatment Outcome | 2017 |
Eccrine squamous syringometaplasia in an allogenic stem cell transplant patient undergoing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Drug Eruptions; Eccrine Glands; Epithelial Cells; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Metaplasia; Stem Cell Transplantation; Transplantation, Homologous | 2017 |
Antibiotic exposure is associated with cutaneous adverse events in hairy cell leukemia patients treated with purine analogues.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Antineoplastic Agents; Cladribine; Cohort Studies; Drug Eruptions; Drug Interactions; Female; Follow-Up Studies; Humans; Incidence; Leukemia, Hairy Cell; Male; Middle Aged; Multivariate Analysis; Pentostatin; Retrospective Studies; Risk Assessment | 2019 |
Cutaneous adverse events associated with purine analogs in the treatment of hairy cell leukemia.
Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Cohort Studies; Cytarabine; Drug Eruptions; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Young Adult | 2019 |
Cutaneous reactions in hairy cell leukaemia treated with 2-chlorodeoxyadenosine and allopurinol.
Topics: Adult; Aged; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Eruptions; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Retrospective Studies | 2003 |
Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia.
Topics: Aged; Antineoplastic Agents; Cladribine; Diagnosis, Differential; Drug Eruptions; Exanthema; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged | 2004 |
Cutaneous reactions after treatment with 2-chlorodeoxyadenosine.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Cladribine; Drug Eruptions; Female; Humans; Leukemia, Hairy Cell; Lymphopenia; Male; Middle Aged; Retrospective Studies | 1996 |
Halogenoderma of the forearm caused by 2-chlorodeoxyadenosine treatment.
Topics: Adult; Antimetabolites, Antineoplastic; Chlorine; Cladribine; Drug Eruptions; Forearm; Humans; Hyperplasia; Infusions, Intravenous; Leukemia, Hairy Cell; Male; Necrosis; Skin | 1996 |
Transient acantholytic dermatosis after treatment with 2-chlorodeoxyadenosine.
Topics: Acantholysis; Adenosine Triphosphate; Cladribine; Drug Eruptions; Enzyme Inhibitors; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Retrospective Studies | 1997 |
2-chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Agents; Cladribine; Drug Eruptions; Eosinophilia; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male | 1997 |
2-chlorodeoxyadenosine-associated transient acantholytic dermatosis in hairy cell leukemia patients.
Topics: Acantholysis; Antineoplastic Agents; Cladribine; Drug Eruptions; Humans; Leukemia, Hairy Cell | 1999 |
2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger.
Topics: Adult; Alopecia; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Cladribine; Cyclophosphamide; Doxorubicin; Drug Eruptions; Drug Resistance, Neoplasm; Female; Fever; Hematologic Diseases; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prednisone; Recurrence; Remission Induction; Salvage Therapy; Treatment Outcome; Vincristine | 1999 |